Anagenex

Closed

South San Francisco, United States · Founded 2019 · $37.2M raised

Founded
2019
Business Model
B2B
Total Funding
$37.2M
Last Round
$30.0M Series AJun 2022
Rounds
2

About

Anagenex was a drug discovery company founded in 2019 and headquartered in South San Francisco, California, that combined DNA-encoded library technology with machine learning to identify small-molecule therapeutics via an iterative directed-evolution platform. Led by founder and CEO Nicolas Tilmans, the company closed a $30 million Series A round in 2022 led by Catalio Capital Management to advance its platform. In mid-2025 Anagenex's technology and team were acquired by another AI-driven drug discovery company backed by The Column Group, and its former domain now redirects to unrelated content.

Summary

Anagenex is an Artificial Intelligence company based in South San Francisco, United States, founded in 2019. It has raised $37.2M in total across 2 rounds, most recently a $30.0M Series A round in Jun 2022. Investors include Lux Capital, Catalio Capital Management and Khosla Ventures.

Tech & App Stack

2 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series ASeries AJun 2022
$30.0M

Sign up to see all 2 rounds

Seed through Series A — per-round amounts, valuations, and who invested in each round.

Investors

Similar Companies

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Anagenex on Indexed.vc
<a href="https://indexed.vc/companies/anagenex"><img src="https://indexed.vc/api/badge/company/anagenex" alt="Anagenex on Indexed.vc" width="260" height="76" /></a>